Walmart, Home Depot adopt health insurer tactic in drug copay battle

Home Depot (HD) Declares $1.03 Quarterly Dividend; 2.3% Yield

Home Depot (NYSE: HD) declared a quarterly dividend of $1.03 per share, or $4.12 annualized.

The dividend will be payable on December 13, 2018, to stockholders of record on November 29, 2018, with an ex-dividend date of November 28, 2018.

The annual yield on the dividend is 2.3... More

CVS Health (CVS) Releases Statement on FDA Decision to Restrict Flavored Tobacco Products

CVS Health (NYSE: CVS) today announced its support for the U.S. Food and Drug Administration's plans to restrict access to flavored tobacco and e-cigarette products in the retail setting and impose stricter age-verification requirements for online sales. In addition to eliminating the sale of tobacco products in 2014, CVS Health has never sold e-cigarettes or vaping devices in any of its CVS Pharmacy locations.

"We applaud the FDA's decision to restrict access to flavored tobacco and e-cigarette products, which have been expertly marketed and targeted at teens and young adults and... More

Alector Initiates Phase 1 Trial of AL002 for Treatment of Patients with Alzheimer’s Disease

Alector, a privately held biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration, today announced the initiation of a first-in-human Phase 1 trial called the INVOKE study, investigating the companys second product candidate, AL002, for the treatment of patients with Alzheimers disease. AL002 targets a triggering receptor expressed on myeloid cells 2 (TREM2), which was identified using large scale human genomic studies of Alzheimers disease patients. In 2017, Alector entered a global strategic partnership with AbbVie (NYSE: ABBV) that includes the AL002 program.

At Alector, we believe that Alzheimers... More